Newly released Survival Data (from ASCO) with Oncosil devise and SOC demonstrates:-
(1) 64% of implanted patients were alive after 12 months.
(2) 50% of implanted patients (21/42) were alive after 16 months.
(3) Average overall survival of 16 months.
Compared to SOC (chemo only) of 9-11 months.
IMO this demonstrates efficacy and should be approved by the regulators.
Ann: Positive Overall Survival data released at ASCO 2019 Chicago, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.160(15.7%) |
Mkt cap ! $15.71M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.18 | $1.03 | $37.05K | 34.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13759 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 4822 | 1 |
View Market Depth
| Last trade - 12.20pm 26/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |